- Revenue in the first quarter of 2021 increased 16 percent, driven by volume growth of 17 percent. - First-quarter 2021 revenue grew 7 percent excluding revenue of $810.1 million from COVID-19 antibodies and also excluding first-quarter 2020 revenue of approximately $250 million from increased
investor.lilly.com
investor.lilly.com
Create attached notes ...
